Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (35)

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

2022

  1. Development and feasibility of 4 checklists for the evaluation of comorbidity in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis: GECOAI Project

    Reumatologia Clinica, Vol. 18, Núm. 2, pp. 114-123

  2. Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review

    BMC Gastroenterology, Vol. 22, Núm. 1

  3. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

2021

  1. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study

    European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382

2019

  1. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364

  2. Very low disease activity, DAPSA remission, and impact of disease in a Spanish population with psoriatic arthritis

    Journal of Rheumatology, Vol. 46, Núm. 7, pp. 710-715

2018

  1. Recommendations for the Management of Comorbidity in Patients With Axial Spondyloarthritis in Clinical Practice

    Reumatologia Clinica, Vol. 14, Núm. 6, pp. 346-359

2017

  1. Minimal disease activity and impact of disease in psoriatic arthritis: A Spanish cross-sectional multicenter study

    Arthritis Research and Therapy, Vol. 19, Núm. 1

2016

  1. Urine metabolome profiling of immune-mediated inflammatory diseases

    BMC Medicine, Vol. 14, Núm. 1

2015

  1. A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881

2014

  1. PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis

    Pharmacogenomics, Vol. 15, Núm. 14, pp. 1763-1769

  2. Role of 18F-FDG PET in patients with infectious endocarditis

    Journal of Nuclear Medicine, Vol. 55, Núm. 7, pp. 1093-1098

2013

  1. Comparación de 2 estrategias de derivación en el diagnóstico de la espondiloartritis axial en España. Estudio RADAR

    Reumatologia Clinica, Vol. 9, Núm. 6, pp. 348-352

2012

  1. Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes

    Human Molecular Genetics, Vol. 21, Núm. 20, pp. 4549-4557

2011

  1. High-dose etanercept in ankylosing spondylitis: Results of a 12-week randomized, double blind, controlled multicentre study (LOADET study)

    Rheumatology, Vol. 50, Núm. 10, pp. 1828-1837

  2. Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis

    Journal of Rheumatology, Vol. 38, Núm. 5, pp. 893-897

2010

  1. Fibromyalgia in patients with ankylosing spondylitis: Prevalence and utility of the measures of activity, function and radiological damage

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 6 SUPPL. 63

2009

  1. Relationship between spinal mobility and disease activity, function, quality of life and radiology. A cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER)

    Clinical and Experimental Rheumatology, Vol. 27, Núm. 3, pp. 439-445

2008

  1. Registro Nacional de Pacientes con Espondiloartritis (REGISPONSER). Análisis descriptivo de los 2.367 pacientes españoles incluidos

    Reumatologia Clinica Suplementos, Vol. 4, Núm. SUPPL. 4, pp. 48-55